Use of Marginal Structural Models in Pharmacoeconomics and Outcomes Research: Application in Antiretroviral Therapy Research
Assessing treatment effectiveness of a time-varying drug regimen in longitudinal and observational outcomes research is difficult. This white paper provides a step-by-step illustration of the use of marginal structural models (MSMs) via an antiretroviral therapy (ART) case study.
Please complete this form to request the full white paper.
A verified business, nonprofit, government, or academic email address is required for fulfillment. We reserve the right not to fulfill requests from competitors and those containing an unverified email address, and apologize for any inconvenience.